Figure 1
Schematic showing the key components and outcomes of HEP-SIM model. HEP-SIM model included patient demographics, HCV disease progression, HCV screening, therapeutic advancement, access to health care including insurance status, and the cost of care and treatment. Outcomes of HEP-SIM include temporal trends in HCV prevalence, awareness rate of HCV-infection, HCV-associated advanced sequelae, and budget impact of different interventions.
Jagpreet Chhatwal, PhD
MGH Inst. for Tech. Assessment
Harvard Medical School
101 Merrimac St. STE 1010
Boston, MA 02114 United States
jagchhatwal@mgh.harvard.edu
Funding source: The creation of Hep C State Policy Simulator was supported by the Centers for Disease Control and Prevention through a Cooperative Agreement Number NU38OT000141 awarded to ChangeLab Solutions; and the National Science Foundation Award numbers 1722614, 1722665, and 1722906. Website's contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention, the Department of Health and Human Services, or the National Science Foundation.
